BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15162443)

  • 1. CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice.
    Yang JQ; Chun T; Liu H; Hong S; Bui H; Van Kaer L; Wang CR; Singh RR
    Eur J Immunol; 2004 Jun; 34(6):1723-32. PubMed ID: 15162443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.
    Yang JQ; Wen X; Liu H; Folayan G; Dong X; Zhou M; Van Kaer L; Singh RR
    Arthritis Rheum; 2007 Apr; 56(4):1219-33. PubMed ID: 17393451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice.
    Yang JQ; Saxena V; Xu H; Van Kaer L; Wang CR; Singh RR
    J Immunol; 2003 Oct; 171(8):4439-46. PubMed ID: 14530371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Langerhans Cells Maintain Local Tissue Tolerance in a Model of Systemic Autoimmune Disease.
    King JK; Philips RL; Eriksson AU; Kim PJ; Halder RC; Lee DJ; Singh RR
    J Immunol; 2015 Jul; 195(2):464-76. PubMed ID: 26071559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
    Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
    Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
    Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
    J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15.
    Yang CH; Tian L; Ling GS; Trendell-Smith NJ; Ma L; Lo CK; Stott DI; Liew FY; Huang FP
    Eur J Immunol; 2008 Jun; 38(6):1664-76. PubMed ID: 18465774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4(+)B220(+)TCRγδ(+) T cells produce IL-17 in lupus-prone MRL/lpr mice.
    Qiu F; Li T; Zhang K; Wan J; Qi X
    Int Immunopharmacol; 2016 Sep; 38():31-9. PubMed ID: 27235595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus nephritis reoccurs following transplantation in the lupus prone mouse.
    Hamar P; Wang M; Godo M; Kokeny G; Rosivall L; Ouyang N; Heemann U
    Lupus; 2010 Feb; 19(2):175-81. PubMed ID: 19946036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
    J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of intermediate T-cell receptor cells expanding in the liver, thymus and other organs in autoimmune lpr mice: parallel analysis with their normal counterparts.
    Iiai T; Kimura M; Kawachi Y; Hirokawa K; Watanabe H; Hatakeyama K; Abo T
    Immunology; 1995 Apr; 84(4):601-8. PubMed ID: 7790034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.
    Chan O; Shlomchik MJ
    J Immunol; 1998 Jan; 160(1):51-9. PubMed ID: 9551955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice.
    Chesnutt MS; Finck BK; Killeen N; Connolly MK; Goodman H; Wofsy D
    Clin Immunol Immunopathol; 1998 Apr; 87(1):23-32. PubMed ID: 9576007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of 4 1BB gene function exacerbates lacrimal gland inflammation in autoimmune-prone MRL-Faslpr mice.
    Vinay DS; Kim JD; Asai T; Choi BK; Kwon BS
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4608-15. PubMed ID: 17898284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of inducible costimulator in the development of lupus in MRL/lpr mice.
    Tada Y; Koarada S; Tomiyoshi Y; Morito F; Mitamura M; Haruta Y; Ohta A; Nagasawa K
    Clin Immunol; 2006 Aug; 120(2):179-88. PubMed ID: 16616645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
    Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H
    Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms.
    Miwa T; Maldonado MA; Zhou L; Yamada K; Gilkeson GS; Eisenberg RA; Song WC
    Am J Pathol; 2007 Apr; 170(4):1258-66. PubMed ID: 17392165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell-specific overexpression of interleukin-27 receptor α subunit (WSX-1) prevents spontaneous skin inflammation in MRL/lpr mice.
    Kido M; Takeuchi S; Sugiyama N; Esaki H; Nakashima H; Yoshida H; Furue M
    Br J Dermatol; 2011 Jun; 164(6):1214-20. PubMed ID: 21332454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.